Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.26B
Enterprise Value3.38B
P/E Ratio-31.73
PEG Ratio0.4
Price/Sales Ratio4.56
Price/Book Ratio3.88
Enterprise/Revenue6.59
Enterprise/EBITDA91.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.15
Operating Margin-0.18
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.11

Income Statement

Revenue606.18M
Revenue/Share5.42
Gross Profit83.5M
EBITDA57.93M
Net Income-73.36M
Diluted EPS-0.64

Balance Sheet

Total Cash76.06M
Total Cash/Share0.63
Total Debt1.4B
Total Debt/Equity1.76
Current Ratio0.93
Book Value Per Share7.28

Price History

52-Week Change18.71
52-Week High32.58
52-Week Low18.44
Moving Average 50 Days24.54
Moving Average 200 Days23.79

Statistics

Average Volume3.75M
Shares Outstanding115.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.18
Payout Ratio-0.27
Last Split FactorN/A
Last Split DateN/A
AD